Volition(VNRX) - 2025 Q4 - Earnings Call Transcript

VolitionRX (NYSEAM:VNRX) Q4 2025 Earnings call April 01, 2026 08:30 AM ET Company ParticipantsAndy Retter - Chief Medical OfficerCameron Reynolds - Group CEOJake Micallef - Chief Scientific OfficerLouise Batchelor - Group Chief Marketing and Communications OfficerTerig Hughes - CFOYi Chen - Managing DirectorConference Call ParticipantsBruce Jackson - Senior AnalystJustin Walsh - Director of Research AnalystSteven Ralston - Senior Analyst and Director of ResearchOperatorGood morning, ladies and gentlemen, an ...